Searchable abstracts of presentations at key conferences in endocrinology

ea0022p368 | Diabetes | ECE2010

Comparative evaluation of serum concentrations of a novel adipocytokine, fibroblast growth factor-21 in patients with type 2 diabetes and obesity

Matuszek Beata , Lenart-Lipinska Monika , Duma Dariusz , Solski Janusz , Nowakowski Andrzej

Fibroblast growth factor-21 (FGF-21) is a novel adipocytokine, which is believed to be involved in improvement of insulin sensitivity and pathogenesis of type 2 diabetes.The aim of the study was comparative assessment of FGF-21 concentrations in serum of patients with type 2 diabetes and evaluation of possible relationships between the studied cytokine and selected clinical and biochemical parameters.Forty-four patients with type 2...

ea0049ep547 | Diabetes complications | ECE2017

Osteoprotegerin as a cardiovascular risk marker in diabetic patients

Dabrowska Anna , Wojtysiak-Duma Beata , Duma Dariusz , Torun-Jurkowska Anna , Mieszkowska Anna , Matyjaszek-Matuszek Beata , Tarach Jerzy

Introduction: ItÂ’s known that type 2 diabetes is an independent risk factor for cardiovascular disease. Osteoprotegerin (OPG), a glycoprotein secreted mainly by osteoblasts, is also produced by heart muscle and vessels. Its role in the pathogenesis of atherosclerosis and future cardiovascular events is still discussed.Material and methods: The study was conducted in 113 patients (48 F, 65 M) with type 2 diabetes mellitus (DM2) and coronary heart dis...